Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 1218790-30-7 | MDL No. : | MFCD15143612 |
Formula : | C19H25BClNO4 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | MRVFRFXOZGTHHX-UHFFFAOYSA-N |
M.W : | 377.67 | Pubchem ID : | 53217207 |
Synonyms : |
|
Num. heavy atoms : | 26 |
Num. arom. heavy atoms : | 9 |
Fraction Csp3 : | 0.53 |
Num. rotatable bonds : | 4 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 105.63 |
TPSA : | 49.69 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | Yes |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | Yes |
CYP3A4 inhibitor : | Yes |
Log Kp (skin permeation) : | -5.14 cm/s |
Log Po/w (iLOGP) : | 0.0 |
Log Po/w (XLOGP3) : | 4.88 |
Log Po/w (WLOGP) : | 4.38 |
Log Po/w (MLOGP) : | 2.93 |
Log Po/w (SILICOS-IT) : | 2.81 |
Consensus Log Po/w : | 3.0 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -5.25 |
Solubility : | 0.00213 mg/ml ; 0.00000565 mol/l |
Class : | Moderately soluble |
Log S (Ali) : | -5.66 |
Solubility : | 0.000829 mg/ml ; 0.00000219 mol/l |
Class : | Moderately soluble |
Log S (SILICOS-IT) : | -5.51 |
Solubility : | 0.00116 mg/ml ; 0.00000307 mol/l |
Class : | Moderately soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 2.0 |
Synthetic accessibility : | 3.52 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
84% | With (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; triethylamine In toluene at 80℃; for 3 h; Inert atmosphere | Pd(dppf)Cl2 (29 mg,0.04 mmol, 3 molpercent) and tert-butyl 5-chloro-3-iodo-1H-indole-1-carboxylate 10 (500 mg, 1.32 mmol) were placed in a dry screwcapvessel with a septum. Then, dry toluene (6.5 mL) was added,and the mixture was degassed with argon (5 min). Dry triethylamine(0.7 mL) and 4,4,5,5-tetramethyl-1,3,2-dioxaborolane(0.3 mL, 2 mmol) were successively added to the mixture, whichwas then stirred at 80 C (preheated oil bath) for 3 h (monitoredby TLC). Subsequently the mixture was cooled to room temperatureand filtered through Celite. The filtrate was concentratedand the residue was purified by flash chromatography (eluent;hexane/ethyl acetate = 10/1) to obtain 418 mg of 11 (totalyield = 84percent). Characterization was in agreement with literaturedata.33,34 1H NMR (500 MHz, CDCl3) d 8.08 (d, J = 8.8 Hz, 1H), 8.00(s, 1H), 7.95 (d, J = 2.1 Hz, 1H), 7.26 (dd, J = 8.8, 2.1 Hz, 1H), 1.65(s, 9H), 1.38 (s, 12H). |
[ 942070-45-3 ]
tert-Butyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate
Similarity: 0.89
[ 893441-86-6 ]
tert-Butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate
Similarity: 0.86
[ 1235451-62-3 ]
tert-Butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indoline-1-carboxylate
Similarity: 0.80
[ 181365-26-4 ]
(1-(tert-Butoxycarbonyl)-1H-indol-3-yl)boronic acid
Similarity: 0.76
[ 470478-90-1 ]
tert-Butyl 4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperazine-1-carboxylate
Similarity: 0.73
[ 1310384-28-1 ]
(1-(tert-Butoxycarbonyl)-5,6-dichloro-1H-indol-2-yl)boronic acid
Similarity: 0.66
[ 870535-27-6 ]
tert-Butyl 4-chloro-2-(hydroxymethyl)-1H-indole-1-carboxylate
Similarity: 0.62
[ 1030832-75-7 ]
2-(4-Chloro-2-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
Similarity: 0.59
[ 863578-21-6 ]
5-Chloro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline
Similarity: 0.58
[ 1073371-77-3 ]
4-Chloro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline
Similarity: 0.58
[ 942070-45-3 ]
tert-Butyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate
Similarity: 0.89
[ 893441-86-6 ]
tert-Butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate
Similarity: 0.86
[ 1235451-62-3 ]
tert-Butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indoline-1-carboxylate
Similarity: 0.80
[ 181365-26-4 ]
(1-(tert-Butoxycarbonyl)-1H-indol-3-yl)boronic acid
Similarity: 0.76
[ 470478-90-1 ]
tert-Butyl 4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperazine-1-carboxylate
Similarity: 0.73
[ 942070-45-3 ]
tert-Butyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate
Similarity: 0.89
[ 893441-86-6 ]
tert-Butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate
Similarity: 0.86
[ 181365-26-4 ]
(1-(tert-Butoxycarbonyl)-1H-indol-3-yl)boronic acid
Similarity: 0.76
[ 2102451-30-7 ]
(1-(tert-Butoxycarbonyl)-1H-indol-4-yl)boronic acid
Similarity: 0.73
[ 388116-27-6 ]
4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole
Similarity: 0.67